Related Experiment Videos
CD40 expression on human lung cancer correlates with metastatic spread
M S Sabel1, M Yamada, Y Kawaguchi
1Division of Surgery, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. msabel@sc3101.med.buffalo.edu
Cancer Immunology, Immunotherapy : CII
|May 24, 2000
Summary
CD40 expression on lung cancer cells correlates with metastatic spread and patient prognosis. CD40-negative tumors indicate better outcomes, suggesting CD40 as a potential prognostic marker for lung cancer.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Diagnostics
Background:
- Lung cancer's poor prognosis is often due to metastasis.
- Predictive markers for metastatic potential are needed for better patient management.
Purpose of the Study:
- To investigate surface markers for predicting lung cancer metastasis.
- To evaluate CD40 as a prognostic indicator in lung cancer.
Main Methods:
- Flow cytometry was used to analyze 18 human lung cancer cell lines.
- Expression levels of EGFR, ICAM-1, Fas, and CD40 were assessed.
Main Results:
- CD40 expression significantly correlated with tumor metastatic spread.
- CD40-negative tumors were stage I without metastasis; CD40-positive tumors frequently showed metastasis.
- CD40-negative patients had better N stage, overall stage, and survival.
Conclusions:
- CD40 expression may drive lung cancer metastasis.
- CD40 serves as a potential prognostic marker for advanced lung cancer.